On November 30, 2011, the generic form of Lipitor, called atorvastatin, became available. Through a special program with Lipitor?s manufacturer, IBC commercial members can continue to obtain brand Lipitor at the same level of cost-sharing they pay for generic drugs. This limited time program is in place for a six-month period, from November 30, 2011, to May 31, 2012.

Members who are currently taking Lipitor received a letter in early November that informed them of the program details. These members will also receive a letter in May as the program concludes to remind them of the program?s end date.

Once the program ends

Starting June 1, 2012, members who have been prescribed Lipitor will be encouraged to make the switch to its generic form, atorvastatin. At that time, brand Lipitor will become a non-formulary brand medication and will only be available at the highest non-formulary level of cost-sharing.

As of June 1, 2012, members who are filling prescriptions for Lipitor should be given generic atorvastatin at their pharmacy to continue paying the lowest formulary level of cost-sharing.

Note: From November 30, 2011, to May 31, 2012, generic atorvastatin will not be covered under IBC prescription drug programs.

Our position on generic drugs

This initiative doesn?t change our position on the benefits of generic drugs. IBC remains committed to their use, as they are typically the lowest-cost option and are often prescribed as preferred alternatives to brand-name medications.